- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 15, 2025 | 14.64M sh |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $39.85M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $52.92M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $73.77M |
| Current Liabilities | FY 2024 · Dec 31, 2024 | $3.78M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.61M |
| Current Assets | FY 2024 · Dec 31, 2024 | $28.15M |
| Current Assets | FY 2024 · Dec 31, 2023 | $28.14M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 5.23M sh |
| Capex | FY 2024 · Dec 31, 2023 | $427K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$22.23M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.83M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $4.64M |
| Total Assets | FY 2024 · Dec 31, 2023 | $57.56M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$4.38 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$4.38 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $3K |
| Net Income | FY 2024 · Dec 31, 2023 | −$22.88M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$21.8M |
| Revenue | FY 2024 · Dec 31, 2023 | $2.04M |